GL1X · GenesisL1 explorer

MolNFT v1 · #104410 · protein

P-glycoprotein cocrystallised with qz-phe

4Q9L · Multidrug resistance protein 1A: “P-glycoprotein cocrystallised with qz-phe”. X-ray diffraction, 1 ligand (30F), 13 pockets (best druggability 0.80). MolNFT v1 #104410 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4Q9L
Type
protein
Length
1,193 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Multidrug resistance protein 1A; (30F)F(30F)F(30F)F peptide
EC
3.6.3.44
UniProt
P21447
Ligands
30F
Pockets
13 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 64% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMultidrug resistance protein 1A (EC 3.6.3.44)protein118764% helix, 9% strandP21447
B, C(30F)F(30F)F(30F)F peptideprotein30% helix, 0% strand—

Ligands and binding sites

  • 30F · (2Z)-2-amino-3-selanylprop-2-enoic acid · ligand · 6 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19380.800.828330F
28690.740.787530F
32700.620.8030empty
41490.560.8134empty
51880.530.7923empty

Interfaces

3 interfaces between chains.

  • A–B · 441 Ų buried · 0 hydrogen bonds · protein-protein
  • A–C · 332 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 93 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 covalent (covalent ligand).

Compared structures

  • 4Q9L · P-glycoprotein cocrystallised with QZ-Phe · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.